| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $30.9M | +209.1% |
| R&D Expense | $114.6M | +40.9% |
| SG&A Expense | $81.1M | +86.0% |
| Operating Income | -$170.1M | -48.0% |
| Interest Expense | $1.1M | +0.7% |
| Pre-tax Income | -$209.5M | -60.6% |
| Income Tax | $185K | +0.0% |
| Net Income | -$209.5M | -60.3% |
| EPS (Basic) | -$3.02 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $205.0M | +130.8% |
| Inventory | $1.8M | — |
| Current Assets | $223.4M | +135.3% |
| Total Assets | $246.4M | +142.7% |
| Current Liabilities | $72.3M | +133.3% |
| Long-term Debt | $40.7M | +0.0% |
| Total Liabilities | $189.2M | +45.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$137.5M | -31.2% |
| Capital Expenditures | $28K | +0.0% |
| Investing Cash Flow | -$9.6M | -116.0% |
| Financing Cash Flow | $263.3M | +380.6% |
| Free Cash Flow | -$137.5M | -31.2% |
| +17.5% |
| EPS (Diluted) | -$3.02 | +17.5% |
| Stockholders' Equity |
| $57.2M |
| +298.0% |